Showing Results : 1-1 of 1
Sort By :


  • LATEST MANUSCRIPTS IN Oncogenesis
  • Simone De Fabritiis, Silvia Valentinuzzi, Gianluca Piras, Ilaria Cicalini, Damiana Pieragostino, Sara Pagotto, Silvia Perconti, Mirco Zucchelli, Alberto Schena, Elisa Taschin, Gloria Simona Berteşteanu, Diana Liberata Esposito, Antonio Stigliano, Vincenzo De Laurenzi, Francesca Schiavi, Mario Sanna, Piero Del Boccio, Fabio Verginelli, Renato Mariani-Costantini. Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients. Oncogenesis. 2023, 12 (1): 10
    Cited : 3
    Read More
  • Gilles Rademaker, Brunella Costanza, Justine Bellier, Michael Herfs, Raphaël Peiffer, Ferman Agirman, Naïma Maloujahmoum, Yvette Habraken, Philippe Delvenne, Akeila Bellahcène, Vincent Castronovo, Olivier Peulen. Correction: Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. 2023, 12 (1): 11
    Cited : 0
    Read More
  • Yi Xiao, Xiaoyu Jiang, Ke Yin, Tianshu Miao, Hanlin Lu, Wenqing Wang, Lijuan Ma, Yinghui Zhao, Chunyan Liu, Yun Qiao, Pengju Zhang. USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer. Oncogenesis. 2023, 12 (1): 12
    Cited : 2
    Read More
  • Fengen Liu, Binhui Xie, Rong Ye, Yuankang Xie, Baiyin Zhong, Jinrong Zhu, Yao Tang, Zelong Lin, Huiru Tang, Ziqing Wu, Heping Li. Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells. Oncogenesis. 2023, 12 (1): 13
    Cited : 5
    Read More
  • Shanyang He, Wei Wang, Zhiyong Wan, Hongwei Shen, Yunhe Zhao, Zeshan You, Jun Liu, Liwen Zhu. Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway. Oncogenesis. 2023, 12 (1): 14
    Cited : 0
    Read More
  • C Liu, L-H Dai, D-Q Dou, L-Q Ma, Y-X Sun. Retraction Note: A natural food sweetener with anti-pancreatic cancer properties. Oncogenesis. 2023, 12 (1): 15
    Cited : 0
    Read More
  • Dimitri Vanauberg, Céline Schulz, Tony Lefebvre. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies. Oncogenesis. 2023, 12 (1): 16
    Cited : 27
    Read More
  • Yu Tang, Wenfang Li, Li Qiu, Xia Zhang, Lei Zhang, Makoto Miyagishi, Hezhao Zhao, Shourong Wu, Vivi Kasim. The p52-ZER6/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway. Oncogenesis. 2023, 12 (1): 17
    Cited : 5
    Read More
  • Chanjun Sun, Kaishang Zhang, Chen Ni, Jiajia Wan, Xixi Duan, Xiaohan Lou, Xiaohan Yao, Xiangnan Li, Ming Wang, Zhuoyu Gu, Pengyuan Yang, Zhenzhen Li, Zhihai Qin. Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release. Oncogenesis. 2023, 12 (1): 18
    Cited : 4
    Read More
  • Huiting Deng, Hailin Liu, Guoyue Yang, Dandan Wang, Ying Luo, Chenglong Li, Zhenchang Qi, Zhili Liu, Peng Wang, Yanfang Jia, Yingtang Gao, Yahui Ding. ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation. Oncogenesis. 2023, 12 (1): 19
    Cited : 1
    Read More
  • Natalia Martínez, Teresa Gragera, María Pilar de Lucas, Ana Belén Cámara, Alicia Ballester, Berta Anta, Alberto Fernández-Medarde, Tania López-Briones, Judith Ortega, Daniel Peña-Jiménez, Antonio Barbáchano, Ana Montero-Calle, Víctor Cordero, Rodrigo Barderas, Teresa Iglesias, Mónica Yunta, José Luís Oliva, Alberto Muñoz, Eugenio Santos, Natasha Zarich, José M Rojas-Cabañeros. PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability. Oncogenesis. 2023, 12 (1): 20
    Cited : 0
    Read More
  • Qi Xu, Xiaoqing Xu, Haimeng Tang, Junrong Yan, Jingjing Li, Hua Bao, Xue Wu, Yang Shao, Cong Luo, Haimin Wen, Jianying Jin, Jieer Ying. Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy. Oncogenesis. 2023, 12 (1): 21
    Cited : 4
    Read More
  • Jie Zhou, Guanming Chen, Jiuling Wang, Bo Zhou, Xuemin Sun, Jinsong Wang, Shu Tang, Xiangju Xing, Xiaofei Hu, Yang Zhao, Yu Peng, Wenjiong Shi, Tingting Zhao, Yuzhang Wu, Hanbing Zhong, Ni Hong, Zhihua Ruan, Yi Zhang, Wenfei Jin. Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer. Oncogenesis. 2023, 12 (1): 22
    Cited : 3
    Read More
  • Carlos Matellan, Dariusz Lachowski, Ernesto Cortes, Kai Ning Chiam, Aleksandar Krstic, Stephen D Thorpe, Armando E Del Río Hernández. Retinoic acid receptor β modulates mechanosensing and invasion in pancreatic cancer cells via myosin light chain 2. Oncogenesis. 2023, 12 (1): 23
    Cited : 3
    Read More
  • Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang. Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis. 2023, 12 (1): 24
    Cited : 6
    Read More
 
 


Journal List
Links
Content Links
About Us

0